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A B S T R A C T
Purpose: Despite efforts to expand contraceptive access for young people, few studies have con-
sidered where young women (age 15–24) in low- and middle-income countries obtain modern
contraceptives and how the capacity and content of care of sources used compares with older users.
Methods: We examined the ﬁrst source of respondents’ current modern contraceptive method
using the most recent Demographic and Health Survey since 2000 for 33 sub-Saharan African coun-
tries. We classiﬁed providers according to sector (public/private) and capacity to provide a range
of short- and long-term methods (limited/comprehensive). We also compared the content of care
obtained from different providers.
Results: Although the public and private sectors were both important sources of family planning
(FP), young women (15–24) used more short-termmethods obtained from limited-capacity, private
providers, compared with older women. The use of long-termmethods among young women was
low, but among those users, more than 85% reported a public sector source. Older women (25+)
were signiﬁcantly more likely to utilize a comprehensive provider in either sector compared with
younger women. Although FP users of all ages reported poor content of care across all providers,
young women had even lower content of care.
Conclusions: The results suggest that method and provider choice are strongly linked, and recent
efforts to increase access to long-term methods among young women may be restricted by where
they seek care. Interventions to increase adolescents’ access to a range of FP methods and quality
counseling should target providers frequently used by young people, including limited-capacity
providers in the private sector.
© 2017 Society for Adolescent Health and Medicine. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
IMPLICATIONS AND
CONTRIBUTION
Using nationally represen-
tative data from 33 sub-
Saharan African countries,
this study comprehensively
describes where young
women obtain modern
contraception and how
their use of providers and
care received compared
with older women. Results
suggest that efforts to
improve quality and
method choice should
target limited-capacity
private providers fre-
quently used by youth.
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It is critical to address unwanted pregnancy among young
women in sub-Saharan Africa, a region with one of the highest
adolescent pregnancy rates and the lowest rates of family plan-
ning (FP) use [1]. Amidst increasing calls to prioritize adolescents’
contraceptive needs, understanding current patterns of adoles-
cent FP service use is vital to achieving universal access to sexual
and reproductive health services [2–4].
High-quality FP care is crucial to preventing unwanted preg-
nancy, particularly among young people. In a study of 40 countries
with Demographic and Health Surveys (DHS), adolescent con-
traceptive practice was characterized by inconsistent use, with
more method failure and discontinuation compared with older
women; the authors suggest young women face more ob-
stacles to use or abandon a method if experiencing side effects
[5]. Health concerns and side effects are frequently cited as reasons
for not using a method [4,6], and youth often have misconcep-
tions about how contraception works [3,7]. Appropriate
counseling, particularly when initiating contraceptive use or
switching methods, is important to addressing knowledge gaps
around pregnancy prevention and consistent contraceptive use
[8,9] and is one of the six elements in the Bruce framework for
quality FP care [10].
However, young people encounter signiﬁcant barriers to ac-
cessing quality health care [11–13], including provider bias, age
restrictions or stigmatization when seeking FP services, and con-
cerns about conﬁdentiality [7,14–16]. World Health Organization
2012 guidelines emphasized the improvement of young peo-
ple’s health services [11], and efforts to make services “youth
friendly” have appeared in several small-scale initiatives, pri-
marily led by nongovernmental organizations (NGOs) and, to some
extent, government-run health facilities [11,17]. Some evidence
suggests that these efforts have increased health service utiliza-
tion, including FP use [3,17,18].
Yet the evidence base for where adolescents seek FP care in
low- and middle-income countries is limited. Much of the evi-
dence on young people’s FP use and provider preferences in sub-
Saharan Africa comes from small-scale, often qualitative, studies
not nationally representative [14,15,19], focused on a limited
number of countries [16,20,21] or studies that do not consider
quality of FP counseling across provider types [22]. The private
sector is an important source of FP care in the region for women
of all ages [23], suggesting that public-sector efforts expanding
youth-friendly servicesmaymiss a signiﬁcant proportion of young
people accessing private providers. Young people frequently utilize
different FP methods compared with older users. As method and
source can be linked, there is a need to consider how youth FP
care seeking compares with older women.
Within global efforts to improve FP access and quality of care,
particularly for youth, it is essential to understand where young
people obtain contraception to inform points of intervention and
cross-country learning. This paper aims to compare how FP
sources and the content of FP care received differs between ad-
olescent (aged 15–19), young (aged 20–24), and older women
(aged 25+) using nationally representative surveys from multi-
ple sub-Saharan African countries.
Methods
DHS are nationally representative, cross-sectional house-
hold surveys of women of reproductive age (15–49 years) with
multistage cluster sampling designs. We utilized the most recent
DHS as of June 2016 for every country in sub-Saharan Africa with
a survey since 2000 and data available for the ﬁrst source of re-
spondents’ current contraceptive method. We examined ﬁrst
source of the user’s current method as DHS content of care ques-
tions refer to the provider where respondents initiated use of the
method.
Results are presented for each country, adjusted for survey
design and survey-speciﬁc weighting. We calculated regional sta-
tistics for sub-Saharan Africa by weighting country-speciﬁc
estimates by the country’s population based on United Nations
population estimates for the median survey year 2012 [24]. We
present 95% conﬁdence intervals; adjusted Wald tests were per-
formed to compare proportions. Analyses were conducted using
Stata/SE v14 (StataCorp, College Station, TX).
Deﬁnitions and population
We examined two populations of women exposed to preg-
nancy risk [25]: (1) those currently using amodern FPmethod and
(2) a subsample ofmodernmethodusers startinguse in the5years
before the survey.We included intrauterine device (IUD), implant,
injection, pill, and male condom as modern methods, according
to Hubacher and Trussell’s deﬁnition [26]. We excluded lacta-
tional amenorrheaandstandarddaysmethod—methods sometimes
considered modern in other studies—as unlike other contracep-
tive commodities and medical procedures, they do not always
require a source or provider.We excluded the 1.2% of respondents
reporting theirmethodas “othermodern” inDHS responseoptions
as these respondents were not asked about the method’s source.
We further excluded female/male sterilization, female condom,
emergency contraception, diaphragm/foam/jelly, and contracep-
tive patch users as thesemethods combined account for less than
6% of modern method users, including less than 1% of users aged
15–19 or 20–24.We considered IUD and implant to be long-term
methods. Because of the small sample size of IUD users among
those aged 15–19 and 20–24 years, IUD and implant users were
combined. Modernmethodmix estimates included the ﬁrst pop-
ulation of respondents, who started their current method at any
point before the survey.
Women were grouped by their age at the time of the survey:
15–19, 20–24, and 25 + years. We used DHS classiﬁcations for
current marital/cohabitation status, grouping currently married
and formerly married respondents as “ever married.”
Categorization of source and sector of provision
DHS respondents were asked for the ﬁrst source of their
current method only if starting continuous use of the method
within 5 years of the survey. Continuous use of the method was
based on the month and the year since the respondent re-
ported using the method “without stopping” [27]. The median
length of use was less than 1 year for modern method users aged
15–24 and 1.5 years for users aged 25+; 99%, 97%, and 87% of users
aged 15–19, 20–24, and 25+, respectively, started current use less
than 5 years before the interview.
Across all 33 countries, we classiﬁed response options for the
ﬁrst source of the user’s current method according to the sector
and the theoretical capacity to provide both short- and long-
termmethods, calling FP providers “comprehensive” or “limited.”
Respondents withmissing or unclassiﬁable sector/capacity of ﬁrst
source (i.e., “other”) accounted for <3% of modern method users
and were excluded. We created six classiﬁcations of FP provid-
ers: (1) public—comprehensive, (2) public—limited, (3)
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private—comprehensive, (4) commercial drug seller—limited, (5)
other private—limited, and (6) informal—limited (see Table 1 for
deﬁnitions and examples). Classiﬁcations were based on provid-
er groupings used in Campbell et al. [23], a review of the literature,
and expert consultations to account for country-level variability
in providers’ capacity. We considered public sector to be
government-provided services and the private sector to include
the classiﬁcations “private—comprehensive,” “commercial drug
seller,” and “other private—limited.” Few countries distinguish faith-
based/NGO providers in DHS response options, and the use of these
providers may be misclassiﬁed as other types of public or private
providers [28]. For countries where they appear as response
options, we grouped comprehensive faith-based/NGO providers
under “private—comprehensive” while noting this combines pro-
viders with potentially different proﬁt motives. Two source
categories, “public—limited” and “other private—limited,” each ac-
counted for <1% of modernmethod users andwere excluded from
age group comparisons of ﬁrst source and content of care.
We used amultilevel multinomialmodeling approach tomodel
the log odds of ﬁrst provider use by age group among condom,
injection, and pill users—methods theoretically accessible at both
comprehensive and limited-capacity providers—while account-
ing for different service environments through controlling for the
user’s urban or rural residence and country-level random effects.
We report the results as model-based predicted probabilities,
along with their 95% conﬁdence interval.
Content of care
To assess the content of care received across providers, we ex-
amined two binary components separately—whether the user was
(1) informed of side effects or not and (2) told of other contra-
ceptive methods or not—and together as a combined variable.
These two components are included in FP2020’s Method Infor-
mation Index for measuring quality of care through information
received during FP consultations [9,29]. The constructed binary
variable for “good” content of care was based on the respon-
dent answering yes to both components. Respondents answering
no to either component but with a missing value for the second
component (<.1%) were classiﬁed as having poor content of care.
Respondents answering yes to one component but with a missing
value for the second component (<.1%) or with missing values
for both components (1%) were excluded from the content of care
analysis. Most countries limited content of care questions to IUD/
implant, injection, and pill users starting use in the 5 years before
the interview, so content of care analysis was limited to those
users for all surveys. Multilevel logistic regression with country-
level random effects estimated the effect of age on receiving good
content of care, adjusting for provider, method, and user
characteristics.
Ethical approval
DHS received government authorization, and used informed
consent and conﬁdentiality assurances. The London School of
Hygiene and Tropical Medicine’s Research Ethics Committee ap-
proved our analyses.
Results
Surveys from 33 countries included in our study were col-
lected in 2009–2015. Table S1 provides a list of countries, survey
years, sample sizes, and modern method users included in the
analysis.
Method mix
As contraceptive type can determine possible sources of pro-
vision, we estimated the modern method mix among current
users aged 15–24 in each country (Figure S1). The majority of
users reported using a short-termmethod, particularly condoms
and injections, which accounted for more than 80% of modern
methods used by this age group.
Figure 1 illustrates regional estimates for modern methodmix
and proportion ever married by single years of age among current
FP users aged 15–24. Condoms were the predominant method
for the youngest users. Methodmix changed rapidly between ages
15 and 24, with declining condom use and increasing pill and
injection use with each year increase in age. The increasing pro-
portion of users utilizing injections was particularly dramatic
between ages 15 and 20, where it closely followed an increas-
ing proportion of users ever married.
Table 1
Deﬁnition and examples for the six classiﬁcations of FP provider by sector and capacity
Classiﬁcation Deﬁnition and examplesa
Public (comprehensive) All government/public service locations capable of providing both short- and long-acting methods
Examples: public hospital, community health center, family doctor, nurse
Public (limited) All government/public service locations not generally capable of providing long-acting methods
Examples: community health worker, public pharmacy/dispensary, government distributor
Private (comprehensive) Private sector locations, including faith-based or NGO-aﬃliated locations, which are capable of providing both short-
and long-acting methods
Examples: private hospital/clinic, private doctor, mission health post, NGO mobile clinic
Commercial drug seller (limited) Commercial drug shops and pharmacies not generally capable of providing long-acting methods
Examples: private pharmacy, private drug store, private dispensary
Other private (limited) Private sector providers not generally capable of providing long-acting methods
Examples: private ﬁeldworker, NGO voluntary community health worker, mission door-to-door
Informal (limited) Commercial retailers, partners, friends, and other locations not considered medical providers or generally capable of
providing long-acting methods
Examples: relatives/friends, street vendor, shop/market, bar, school
FP = family planning; NGO = nongovernmental organization.
a There were 109 unique family planning provider response options in the 33 surveys, so only examples are shown.
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Provider type by method
Regional estimates for sector and capacity of ﬁrst provider of
the respondent’s current method among users aged 15–19 and
20–24 are shown in Table 2. The public sector, both comprehen-
sive and limited providers, was the ﬁrst source of the current
method for 39.0% of users aged 15–19 and for 55.4% of users aged
20–24. Method type was strongly patterned by the ﬁrst source.
Approximately 80% of condom users reported a commercial drug
seller or an informal provider (which included the respon-
dent’s partner) as their ﬁrst source for both age groups. IUD/
implant was a small proportion of the methods used by women
aged 15–19 or 20–24, but was overwhelmingly provided by com-
prehensive public providers.
When compared by FP users’ marital status (Table S2), more
than 65% of ever-married women aged 15–19 and 20–24 re-
ported a comprehensive public provider, whereas more than 65%
of never-married women aged 15–19 and 20–24 reported com-
mercial drug sellers or informal providers as the ﬁrst source of
their method. This was driven by the large proportion of condom
users among never-married modern method users. Within both
age groups, larger proportions of ever-married women used a
comprehensive public provider compared with never-married
women across all methods.
Comparing providers by age
There was a clear age gradient in the use of some FP provid-
ers (Figure 2A). Comprehensive public providers were the most
used ﬁrst source among all age groups; this was particularly seen
among older women (age 25+) where nearly 70% of modern FP
users ﬁrst obtained their method from this provider. The use of
comprehensive providers (from either sector) increased signiﬁ-
cantly with age (p < .001). Among adolescents aged 15–19, 49.4%
received their method from a comprehensive provider in either
the public or private sector compared with 65.2% among women
aged 20–24 and 81.4% among those age 25 + . Half of modern
method users aged 15–19 reported obtaining their method from
commercial drug sellers or informal providers. Among 15- to 19-
year-olds using informal providers, the vast majority were using
condoms obtained from a relative/friend/partner or commer-
cial retailers (“shop/market”).
Table S3 shows providers by age group for each country. In
24 of the 33 countries, comprehensive public provider use in-
creased with increasing age, in line with regional-level estimates.
Among the nine countries without a clear trend of increasing
public-sector use by age group, three countries (Burundi, Rwanda,
and Zambia) had comprehensive public provider use above 80%–
90% across all three age groups. The regional trend of decreasing
use of informal providers with increasing age was observed in
all but four countries—Ethiopia, Liberia, Mali, and Sierra Leone—
where the use of this provider category was low (<1%–8%) across
all three age groups, and condoms accounted for less than 10%
of the modern method use among users aged 15–24. Ten coun-
tries showed declining use of commercial drug sellers with
increasing age, as seen in the regional-level estimates, but in 10
countries, the use of commercial drug sellers peaked at ages 20–
24. In 12 countries, the use of comprehensive private or
commercial drug sellers was less than 5% across all three age
groups.
Figure 2B shows the ﬁrst providers by the respondent’s age
among condom users. Women aged 25+ were more likely to
obtain their condom from a comprehensive public provider com-
pared with the two younger age groups (p < .001), whereas half
of condom users aged 15–19 reported an informal source. Com-
mercial drug sellers were the leading source for condom users
aged 20–24 and 25+. A multilevel model, adjusted for resi-
dence and country-level random effects, showed a similar pattern
of provider usage. The predicted probability of condom users aged
15–19 accessing comprehensive public providers was 10.8%, com-
pared with 16.4% and 26.2% of condom users aged 20–24 and 25+,
respectively (Table S4). Among injection users, the overwhelming
Figure 1. Change in method mix by single years of age, 15–24, among modern FP users.
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majority across all age groups used comprehensive public pro-
viders (Figure 2C). A slight age gradient favored the youngest
injection users in utilizing comprehensive private providers, with
some evidence that injection users aged 15–19 were more likely
to use these providers compared with those aged 25+ (p = .025)
(Figure 2C), although differences in the multilevel model were
not signiﬁcant (Table S4). More than 55% of pill users (Figure 2D)
reported a comprehensive public provider as ﬁrst source across
all three age groups, but commercial drug sellers were the ﬁrst
source for a quarter of all pill users.
Comparing content of care by age
Figure 3 shows the proportion of users by age group report-
ing good content of care by the ﬁrst source of their current
method. Less than 55% of IUD/implant, injection, or pill users re-
ported good content of care across all provider categories and
age groups. There was a clear age gradient in better content of
care among comprehensive private providers where 29.7% of 15-
to 19-year-olds and 40.3% of 20- to 24-year-olds compared with
49.9% of those aged 25+ received both care components (p < .001).
Additionally, a slightly higher proportion of women aged 25+ re-
ceived good content of care from comprehensive public providers
compared with women aged 15–19 or 20–24. Users obtaining
their method from commercial drug sellers or informal provid-
ers reported the lowest levels of good content of care. Among
informal providers, women aged 15–19 were signiﬁcantly less
likely to report good content of care (p < .001) compared with
women aged 20–24 and 25+. A multilevel model with country-
level random effects showed that, after adjusting for the provider,
method, and respondent characteristics, users aged 15–19 and
20–24 had 35% and 21% lower odds, respectively, of receiving good
content of care (p < .001) compared with users aged 25+ (Table
S5).
Of the two components, the proportion of users told of other
FP methods was higher than the proportion informed of side
effects across all providers and all three age groups (results not
shown). Nonetheless, a greater proportion of older women re-
ported methods counseling from comprehensive public/private
providers compared with users aged 15–19 and 20–24 (p < .001).
Discussion
The present study included 33 countries—whose popula-
tions account for 87% of the population of sub-Saharan Africa—and
provided a comprehensive, up-to-date picture of adolescent FP
use by source of provision and method and how source and
content of care compare with that of older women. We in-
cluded more countries than other studies on the subject and
uniquely categorized providers by both sector and capacity to
provide short- and long-term methods. The striking but not un-
expected results showed that younger women used more short-
term methods from limited-capacity providers, which are
predominantly outside the public sector. Half of FP users aged
15–19 utilized commercial drug sellers or informal providers as
the ﬁrst source of their method. In contrast, nearly 7 in 10 older
women accessed FP from comprehensive public providers. IUD/
implant use among women aged 15–19 and 20–24 was low, but
among those using, more than 85% reported a public-sector
source. Although FP users of all ages reported poor content of
care, as documented previously [23], young women had an even
lower content of care.Ta
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Figure 2. Comparing ﬁrst providers of current modern method by age group among users who started using the method within 5 years of the survey among (A) all
modern method users, (B) condom users, (C) injection users, and (D) pill users.
Figure 3. Percent who received good content of care from different providers, comparing by age group among current users of IUD/implant, injection, and pill who
started using the method within 5 years of the survey.
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Our ﬁndings are consistent with a previous study that found
young women in low- and middle-income countries were more
likely to source FP from the private sector compared with older
women [22]. This ﬁnding is seemingly at odds with Biddlecom
et al. [16], who found adolescents overwhelmingly prefer public
facilities because of perceived quality. By examining current FP
users and self-reported ﬁrst source, our study moved beyond
stated preferences to patterns of actual use. Although compre-
hensive public providers were signiﬁcant sources of FP care, young
women also utilized a variety of private and informal provid-
ers. This was strongly patterned by the respondent’s method.
Additional research is needed to understand how young people
decide where to access FP care, including whether the method
determines provider or vice versa, and how this decision-
making process is inﬂuenced by social standing changes that
accompany marriage and childbearing.
The change in the method mix between ages 15 and 24 high-
lights the divergent needs of adolescents and young women and
the potential motivations for method use. For single women in
high HIV/sexually transmitted infection (STI) risk settings,
condoms, obtained from commercial sources or the respon-
dent’s male partner, offer dual protection from pregnancy and
STIs, but condoms become less acceptable in longer-term rela-
tionships, including marriage [30], leading to a need for wider
contraceptive choice from easily accessible and acceptable
providers.
Research on young people’s FP care preferences has found that
characteristics of service, such as friendly, nonjudgmental pro-
vision and conﬁdentiality [14,19,20], were the most important
factors in deciding where to seek care. Our study highlighted the
important role of commercial drug sellers as an FP source among
users aged 15–19 and 20–24 in most countries considered here.
Embarrassment in seeking contraceptive services has been re-
ported as a common barrier [16] and may be resulting in young
women utilizing providers (like a local pharmacy) offering faster,
more discreet services comparedwith a clinic, where amore com-
prehensive range of FP methods might be available. Some
characteristics of these limited-capacity, private-sector provid-
ers, for example, accessible locations, extended opening hours,
quick service, and conﬁdentiality [31], may be relevant to public-
sector providers aiming to increase youth access and utilization.
Countries diverging from the regional pattern of increasing public
provider use with increasing age—namely, Burundi, Rwanda, and
Zambia—had high comprehensive public provider use for all ages.
Further research should consider how these countries have ap-
proached youth-friendly service implementation in the public
sector.
Despite young people’s perceptions of quality in the public
sector [16], we found public provider users reported only slightly
higher content of care compared with other provider catego-
ries, and content of care was poor across the board, especially
for adolescents and young women. There was a surprising yet
clear age gradient in increasing content of care among compre-
hensive private providers. Additionally, younger women more
commonly accessed care from commercial drug sellers and in-
formal sources—providers with the lowest FP counseling
levels—compared with older women. This ﬁnding has implica-
tions for FP use as good content of care is particularly important
when users initiate or switch methods to ensure informed choice
and to help users utilize methods effectively. Additional focus is
also needed on how to reach adolescents and young people with
FP information through alternative sources, includingmobile tech-
nology and mass media, that enhance high-quality counseling
provided at the point of FP consultation. Reducing contracep-
tive discontinuation among women wishing to avoid pregnancy
is critical to reducing high levels of unmet need, particularly in
sub-Saharan Africa [32].
Limitations
The present study was limited by the accuracy of women’s
recall of the provider and content of care received during con-
sultation. Although some users of IUD/implants, injections, or pills
needed to recall counseling received up to 5 years before the in-
terview, the median lengths of use for these methods were 6, 9,
and 13 months for users aged 15–19, 20–24, and 25+, respec-
tively. The study was also limited in assessing FP source by DHS
response options, which may not reﬂect the full range of pro-
viders available in the country. For example, 10 surveys lacked
a separate response option for NGO/faith-based providers. Inmany
countries considered here, the line between “public” and “private”
providers may be blurred or diﬃcult for respondents to assess,
particularly where private providers are subcontracted or receive
government funds to operate.
Additionally, 1% of long-term method users aged 15–19 and
20–24 reported obtaining their method from limited-capacity pro-
viders; these users were largely from Mali and Sierra Leone,
possibly reﬂecting the country-speciﬁc scope of practice among
providers not captured in our categorizations. Across the 33 coun-
tries included in the present study, there were 109 unique FP
provider types, reﬂecting the large variety of providers operat-
ing within countries and captured by DHS response options.
Although efforts were made to consult experts familiar with
country contexts to appropriately classify providers according to
their theoretical capacity to provide short- and long-term
methods, our categorizations may not reﬂect variation in indi-
vidual provider capacity. We recognize that not all providers
deemed “comprehensive” actually offer IUD/implant because of
differences in regulation and health system constraints.
DHS does not ask male condom users about the content of
care components considered here. It remains unclear how content
of care for the youngest FP users—those more likely to utilize
condoms—compares. Our estimates may be upwardly biased as
we do not know content of care received among users who ini-
tiate and then discontinue their method. Additionally, our binary
indicator of “good” content of care may not capture misinfor-
mation given about the safety, eﬃcacy, and management of side
effects for different methods [14].
There was notable heterogeneity across countries, and re-
gional estimates should be interpreted with some caution. We
provide country-level estimates for several indicators in supple-
mentary tables and note where countries follow or diverge from
regional estimates. Because of the small sample sizes of FP users,
especially 15- to 19-year-olds, in many countries, it was not pos-
sible to compare country-level age-disaggregated results by
method and provider category. Although multilevel models, ad-
justed for user’s residence and country-level effects, conﬁrmed
provider use patterns by age separately among condom, injec-
tion, and pill users, it was not possible to account for other
potentially important factors because of the small sample sizes.
Despite these limitations, our results suggest that interven-
tions to improve youth FP services focusing solely on the public
sector may encounter a coverage ceiling. Strategies engaging the
private sector offer opportunities to achieve increased and, with
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additional intervention and suﬃcient regulation, quality contra-
ceptive coverage for youth [33]. The results suggest that uptake
of certain methods and diversifying the method mix to meet the
reproductive needs of adolescents and young women may be
limited by method availability across speciﬁc provider types.
Efforts expanding the range of methods offered by limited-
capacity, nonfacility providers (like drug shops or community-
based workers) suggest potential paths to reaching young people
with more method choice [31,34,35], although more research is
needed to understand how to improve highly variable quality.
Recent studies in Senegal and Uganda of women’s self-
administration and community health worker provision of Sayana
Press (a single-use injectable contraceptive) suggest possible in-
terventions suitable for other countries in the region [36,37].
As numbers of young people in sub-Saharan Africa grow in
the coming decades [1], health systemsmust be equipped tomeet
their FP needs with appropriate care and counseling, including
HIV/STI protection. Improving contraceptive coverage among
youngwomen in need requires providers who are accessible (easy
to visit, welcoming environments), stocked with a range of
methods, and support informed choices [3]. Although quality
needs improvement across all provider categories, policy makers
concerned with youth FP programs should consider interven-
tions targeting private providers to improve quality of care and
capacity to offer a variety of methods at sources frequently used
by young people.
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